U.S. health officials are asking for research about how hemp-derived cannabinoids and other plant-derived treatments affect chronic pain.
The review will focus on:
- The benefit of cannabinoids for adults with chronic pain, including specific efficacy outcomes.
- The harm of cannabinoids in adults with chronic pain, including adverse effects.
- Cannabinoid delivery.
- Synthetic cannabinoids.
Submissions are due by Jan. 4.